专题:Phosphodiesterase function and regulation

This cluster of papers focuses on the molecular regulation and clinical applications of cyclic nucleotide phosphodiesterases (PDEs), particularly in the context of cAMP signaling, schizophrenia genetics, neuronal development, therapeutic targeting, compartmentalized signaling, Alzheimer's disease treatment, cardiac function regulation, and the development of phosphodiesterase inhibitors.
最新文献
Bipolar Disorder: An Update on Neurobiology and Treatment

article Full Text OpenAlex

Postnatal reduction of eIF4E overexpression in D1-SPNs ameliorates KCNQ channel dysfunction, hyperexcitability and ASD-like behaviours

article Full Text OpenAlex

ADT-030, a novel PDE10 inhibitor, demonstrates potent antitumor activity in pancreatic ductal adenocarcinoma

article Full Text OpenAlex

Cell Type‐Specific Loss of SIRT1 in Central Amygdala Leads to Depression‐Like Behaviors by Altering Neuronal Excitability in Mice

article Full Text OpenAlex

Preparation, Characterization and In-Vitro Efficacy of Roflumilast Nanosuspension in Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease

article Full Text OpenAlex

Digital memory assessments and plasma pTau217 enable efficient preclinical Alzheimer’s trials

article Full Text OpenAlex

Lithium Therapeutic Functions: An Update on Pharmacokinetics, Pathophysiological Mechanisms of Action, Toxicity, and Side Effects

article Full Text OpenAlex

The spectrum of bipolar disorder in older adults

article Full Text OpenAlex

Long‐Term Effect of Acetylcholinesterase Inhibitors on Behavioral and Psychological Symptoms of Dementia

article Full Text OpenAlex

Differential regulation of cyclic adenosine monophosphate by phosphodiesterase 3A discriminates thrombin-induced protease activated receptor 1– and 4–dependent platelet activation

article Full Text OpenAlex

近5年高被引文献
Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies

review Full Text OpenAlex 747 FWCI350.4702

Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis

article Full Text OpenAlex 204 FWCI30.1051

Receptor-associated independent cAMP nanodomains mediate spatiotemporal specificity of GPCR signaling

article Full Text OpenAlex 181 FWCI15.5423

Reimagining cholinergic therapy for Alzheimer’s disease

review Full Text OpenAlex 159 FWCI26.6793

cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach

review Full Text OpenAlex 125 FWCI16.4303

CaMKII as a Therapeutic Target in Cardiovascular Disease

review Full Text OpenAlex 115 FWCI9.4866

BI 1015550 is a PDE4B Inhibitor and a Clinical Drug Candidate for the Oral Treatment of Idiopathic Pulmonary Fibrosis

article Full Text OpenAlex 113 FWCI8.9432

An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022

review Full Text OpenAlex 112 FWCI8.8564

Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress

review Full Text OpenAlex 108 FWCI18.6053

A high-performance genetically encoded fluorescent indicator for in vivo cAMP imaging

article Full Text OpenAlex 104 FWCI8.7704